july, 2020

10jul10:00 am11:30 amCancer Immunotherapy: What Do Non-Oncology Nurse Practitioners Need to Know?E610:00 am - 11:30 am MDT Speaker: Laura Zitella CE Credit / Rx Credit: 1.5 CE / 1.5 Rx

Event Details

Immune checkpoint inhibitors are a new class of cancer treatments that help the body’s own immune system recognize and destroy cancer cells. However, activating the immune system may cause a form of autoimmune reaction that can affect any organ or tissue. Most immune-related adverse events (irAE) are mild to moderate and reversible, if detected early and addressed appropriately. These irAE most commonly affect the skin, colon, lungs, liver and endocrine organs, and some can be permanent (hypothyroidism) or life threatening (myocarditis). Non-oncology NPs play an integral role in the care of cancer patients and survivors and NPs in specialties such as dermatology, GI, and endocrinology may be consulted regarding the management of an immune-related adverse event. Equip yourself with knowledge about immunotherapy and immune-related adverse events, so you can communicate with the oncology team and work together to address all the patient’s medical needs.

Laura Zitella MS, RN, ACNP-BC, AOCN; Nurse Practitioner and Associate Clinical Professor, Hematology/Oncology, University of California San Francisco; San Francisco CA


(Friday) 10:00 am - 11:30 am


Leave a Reply

Avatar placeholder